Searched for
NILOTINIB CAPSULES
Stocks in news: Kwality Walls, AU Small Finance Bank, YES Bank, PB Fintech, Tata PowerIndian markets faced pressure on Friday, losing some recent gains due to cautious global sentiment and profit-taking. Several companies lik...
Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDACipla USA is recalling over 400 cartons of its generic anti-cancer drug Nilotinib Capsules (150 mg and 200 mg) due to a manufacturing issue...
Cipla recalls over 400 cartons of cancer drug in US: FDACipla USA is recalling over 400 cartons of its anti-cancer drug Nilotinib Capsules. The recall is due to a manufacturing issue where the ca...
Cipla targets $1 bn US revenue in FY27Cipla aims for $1 billion in US sales by FY27, offsetting Revlimid's patent expiry with new launches, particularly in respiratory generics ...
Cipla shares in focus after U.S. FDA nod for Leukemia drugCipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib...
Aurobindo Pharma shares rise 3% after subsidiary signs license for generic version of Nilotinib CapsulesShares of Aurobindo Pharma went up by 3% after the company announced that its subsidiary Eugia Pharma has signed a voluntary license with M...
Aurobindo Pharma arm signs pact with Medicines Patent Pool to develop anti-cancer drugIndia's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Me...